Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000930413-08-000315
Filing Date
2008-01-14
Accepted
2008-01-14 14:22:19
Documents
1
Period of Report
2008-01-03

Document Format Files

Seq Description Document Type Size
1 c51987_ex.html 3  
1 c51987_ex.xml 3 2833
  Complete submission text file 0000930413-08-000315.txt   4635
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Issuer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 1106
SIC: 8071 Services-Medical Laboratories

Mailing Address C/O ENZO BIOCHEM, INC 527 MADISON AVENUE NEW YORK NY 10022
Business Address 212-583-0100
FISCHETTE CHRISTINE (Reporting) CIK: 0001423674 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-09974 | Film No.: 08528251